Analysis of morbidity in liver transplant recipients following human albumin supplementation: A retrospective pilot study

Progress in Transplantation

Volumn 16, Issue 3, 2006, Pages 197-205

  Johnson, Peter N ^a   Romanelli, Frank ^b   Smith, Kelly M ^b   Ranjan, Dinesh ^b   Butler, J S ^b   Clifford, Timothy M ^b  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF PHARMACY   (United States)

^b UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SERUM ALBUMIN;

ACUTE KIDNEY FAILURE; ADULT; AGED; APACHE; ARTICLE; BLOOD COMPONENT THERAPY; CARDIOVASCULAR DISEASE; CROSS INFECTION; FEMALE; GRAFT REJECTION; HOSPITAL READMISSION; HUMAN; INCIDENCE; LENGTH OF STAY; LIVER TRANSPLANTATION; MALE; METHODOLOGY; MIDDLE AGED; MORBIDITY; MORTALITY; PILOT STUDY; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICAL MODEL; STATISTICS; UNIVERSITY HOSPITAL;

ACADEMIC MEDICAL CENTERS; ADULT; AGED; APACHE; BLOOD COMPONENT TRANSFUSION; CARDIOVASCULAR DISEASES; CROSS INFECTION; FEMALE; GRAFT REJECTION; HOSPITAL MORTALITY; HUMANS; INCIDENCE; KIDNEY FAILURE, ACUTE; LENGTH OF STAY; LINEAR MODELS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MORBIDITY; PATIENT READMISSION; PILOT PROJECTS; RETROSPECTIVE STUDIES; RISK FACTORS; SERUM ALBUMIN;

EID: 33750621991     PISSN: 15269248     EISSN: None     Source Type: Journal    
DOI: 10.1177/152692480601600303     Document Type: Review

References (32)

1. Tullis JL. Albumin: Guidelines for clinical use. JAMA. 1977; 237:460-463.
2. Sgouris JT, Rene A, eds. Proceedings of the Workshop on Albumin. Bethesda, Md: National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health, Education, and Welfare; 1975:76-925. Publication No. 76-925.
3. Albumin (human) 25% [prescribing information]. Berne, Switzerland: ZLB Bioplasma AG; August 2000. US license no. 1598.
4. Tullis JL. Albumin: Background and use. JAMA. 1977;237: 355-360.
5. Cochrane Injuries Group Albumin Reviewers. Human albumin administration in critically ill patients: Systemic review of randomized controlled trials. BMJ. 1998;317:235-240.
6. Wilkes MM, Navickis RJ. Patient survival after human albumin administration. Ann Intern Med. 2001;135:149-165.
7. The SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med. 2004;350:2247-2256.
8. Adam R, Astarcioglu I, Castaing D, Bismuth H. Ringer's lactate versus serum albumin as a flush solution for UW preserved liver grafts: Results of a prospective randomized study. Transplant Proc. 1991;23:2374-2375.
9. Gaber AO, Thristlewaite JR, Busse-Henry S, et al. Improved results of preservation of hepatic grafts preflushed with albumin and prostaglandins. Transplant Proc. 1988;5:992-993.
10. Trull A, Hughes V, Cooper D, et al. Influence of albumin supplementation on tacrolimus and cyclosporine therapy early after liver transplantation. Liver Transplant. 2002;8:224-232.
11. Haynes GR, Navickis RJ, Wilkes MM. Albumin administration: What is the evidence of clinical benefit? A systematic review of randomized controlled trials. Eur J Anaesthesiol. 2003;20:771-793.
12. Wiesner R, Edwards E, Freeman R, et al. Model for endstage liver disease (MELD) and allocation of donor livers. Gastroenterology. 2003;124:91-96.
13. Knaus WA, Wagner DP, Draper EA, et al. The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest. 1991;100:1619-1636.
14. Keeffe EB. Liver transplantation: Current status and novel approaches to liver replacement. Gastroenterology. 2001; 120:749-762.
15. Bellomo R, Ronco C, Kellum JA, et al. Acute renal failure: Definition, outcome measures, animal models, fluid therapy and information technology needs. The Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8:R204-R212.
16. von Hoegen I, Walker C. Safety of human albumin based on spontaneously reported serious adverse events. Crit Care Med. 2001;29:994-996.
17. Vincent JL, Wilkes MM, Navickis RJ. Safety of human albumin- serious adverse events reported worldwide in 1998- 2000. Br J Anaesth. 2003;91:625-630.
18. Vincent JL, Navickis RJ, Wilkes MM. Morbidity in hospitalized patients receiving human albumin: A meta-analysis of randomized, controlled trials. Crit Care Med. 2004;32:2029-2038.
19. Sanfey H. Gender-specific issues in liver and kidney failure and transplantation: A review. J Womens Health. 2005;7:617-626.
20. Neugarten J, Silbiger SR. The impact of gender on renal transplantation. Transplantation. 1994;58:1145.
21. Lahitaa RG. Sex hormones and systemic lupus erythematosus. Rheum Dis Clin North Am. 2000;26:951.
22. Kahn D, Gavaler JS, Makowka L, Van Thiel DH. Gender of donor influences outcome after orthotopic liver transplantation in adults. Dig Dis Sci. 1993;38:148514.
23. Kouli F. Impact of donor/recipient traits independent of rejection on long-term renal function. Am J Kidney Dis. 2001; 37:356.
24. Therapondos G, Flapan AD, Plevris JN, Hayes PC. Cardiac morbidity and mortality related to orthotopic liver transplantation. Liver Transplant. 2004;10:1441-1453.
25. Ahmed SS, Howard M, ten Hove W, et al. Cardiac function in alcoholics with cirrhosis: Absence of overt cardiomyopathy- myth or fact? J Am Coll Cardiol. 1984;3:696-702.
26. Watt KDS, McCashland TM. Transplantation in the alcoholic patient. Semin Liver Dis. 2004;24:249-255.
27. Prograf (tacrolimus) [package insert]. Deerfield, Ill: Fujisawa Healthcare, Inc; 2004.
28. Dawidson IJ, Sandor ZF, Coorpender L, et al. Intraoperative albumin administration affects outcome of cadaver renal transplantation. Transplantation. 1992;53:774-782.
29. Soni N. Wonderful albumin? BMJ. 1995;310:887-888.
30. Gould SA, Seghal LR, Seghal HL, et al. Hypovolemic shock. Crit Care Clin. 1993;9:239-259.
31. Lucas CE, Ledgerwood AM. Physiology of colloid-supplemented resuscitation from shock. J Trauma. 2003;54:S75-S81.
32. Delvin JW, Barletta JF. Albumin for fluid resuscitation: Implications of the Saline versus albumin fluid evaluation. Am J Health-Syst Pharm. 2005;62;637-642.